- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
Last year brought enough investor pain to reshape the entire industry.
David Cole, chairman of the Center for Automotive Research, believes there could be a happy ending for GM and Ford.
The automaker already has received union concessions, but shareholders face dilution over how GM reduces its debt load.
Even if Democrats manage to end its "private fee-for-service" business, the company's confident that everything will work out in the end.
Companies such as Humana and UnitedHealth could benefit if the Democrats institute universal health care.
For-profit providers face a tough road amid likely Medicare reforms.
The longtime oilman wants to cut our dependence on foreign oil.
The company gets a little murkier on 2009.
The company stands to make out well if the oilman's alternative-energy plan moves forward.
The drugstore chain is coming out with a health care pass that will lower generic drug prices.